Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Tigermed Consulting And Qiming Venture Partners To Jointly Inject Funds Into MacroStat

This article was originally published in PharmAsia News

Executive Summary

China CRO Tigermed Consulting will join Qiming Venture Partners to inject funds into MacroStat, China's only international CRO, which specializes in statistical analysis for clinical trials. Tigermed will extend its business scope and strengthen its professional expertise in biostatistics through the collaboration, speeding up its clinical research globalization strategy. Established in 2005, Shanghai-based MacroStat China has formed strategic partnership with many pharmaceutical and biotech enterprises. After the new capital injection, MacroStat will be able to expand rapidly in the short term (Click here for more - Chinese Language)



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts